This Company Aims To Bring Down The Cost Of Your Medicine With Price Transparency

hen your doctor writes a prescription for medication, A.J. Loiacono thinks that one of the biggest mysteries in life is how the pharmacy arrives at the price you end up paying.

It was at that point, in 2017, that he decided “enough’s enough.” Loiacono and two of his colleagues, Joseph Alexander and Ryan Kelly, founded pharmacy benefit manager Capital Rx with a goal of offering more transparency for prescriptions. To that end, his company announced Wednesday that it now has a consumer prescription card, Capital Rx Advantage.

But it’s not always easy to figure out where drug prices come from, says Loiacono. That’s thanks to some of the convoluted connections between insurers, plan providers, suppliers and pharmacies. “When I read my first PBM contract, I was like, ‘Is there an amendment? Is there a schedule? Where are the drug prices?’ Because if you’re coming from manufacturing and the supply chain, everything has a price. And my colleagues on the payer side would be like, ‘We don’t have drug prices.

Capital Rx, which now serves as a PBM for organizations and manages costs for over 500,000 people so far, has made the first step in managing drug price transparency. Rather than rely on complicated formulas, the company bases its prices on the National Average Drug Acquisition Cost pricing, a benchmark developed by the federal government. This benchmark is married with its pricing model, which the company says provides visibility into drug unit pricing with minimal variability.

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Covid-19 Resurgence Raises Borrowing Costs for Travel-and-Leisure CompaniesThe Delta variant's rapid spread is raising borrowing costs for companies such as cruise operator Royal Caribbean, as investors recalculate the risks facing the leisure-and-travel industry Well this leaves more profitable lending opportunities on the table for investors who understand the true survival rate of covid. Because there is no cure stopthemandes Fauci, Daszak, Andersen el tried to cover up the true origin of Covid-19 pandemic that killed millions just to protect their positions. They deserve no quarter from the rest of the human race. By funding &defending the CCP lab in Wuhan they have blood of 4m people in their hands.
Herkunft: WSJ - 🏆 98. / 63 Weiterlesen »

Disney Parks Swings To Quarterly Profit; Company Expects Another $1B In Total Covid Costs For Fiscal 2021Disney’s parks and resorts swung to the black last quarter in a slow turnaround for one of the nation’s sectors hardest hit by the global pandemic. On a conference call with analysts po…
Herkunft: DEADLINE - 🏆 109. / 63 Weiterlesen »